financetom
Business
financetom
/
Business
/
QuantumScape Q2 Loss Narrows -- Shares Drop After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
QuantumScape Q2 Loss Narrows -- Shares Drop After Hours
Jul 24, 2024 3:10 PM

05:46 PM EDT, 07/24/2024 (MT Newswires) -- QuantumScape ( QS ) reported Q2 diluted loss Wednesday of $0.25 per share, narrowing from a loss of $0.26 a year earlier.

Four analysts polled by Capital IQ expected $0.23 loss per share.

No revenue was reported for the quarter ended June 30.

The company had approximately $214.4 million in cash, cash equivalents and restricted cash as of the end of Q2.

Shares were down 5% in extended session.

Price: 7.08, Change: -0.38, Percent Change: -5.10

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period
Mar 10, 2026
Company Announcement Transaction adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolio Transaction anticipated to be accretive to Genmab’s EBITDA by end of 2029   COPENHAGEN, Denmark--(BUSINESS WIRE)-- Genmab A/S ( GMAB ) (“Genmab”) announced today that the conditions, including the minimum tender condition, to the previously announced tender offer (the “Offer”) by Genmab Holding II...
Novo Nordisk launches blockbuster diabetes drug Ozempic in India
Novo Nordisk launches blockbuster diabetes drug Ozempic in India
Mar 10, 2026
Dec 12 (Reuters) - Danish drugmaker Novo Nordisk launched its blockbuster diabetes drug Ozempic in India on Friday. Ozempic, a once-weekly injectable approved by the U.S. Food and Drug Administration in 2017 for type 2 diabetes, has become a global bestseller and is widely used off-label for weight loss due to its appetite-suppressing effects. ...
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period
Genmab Announces Completion of Tender Offer for Outstanding Common Shares of Merus N.V. and Commencement of Subsequent Offering Period
Mar 10, 2026
Company Announcement Transaction adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolioTransaction anticipated to be accretive to Genmab’s EBITDA by end of 2029 COPENHAGEN, Denmark; December 12, 2025 – Genmab A/S ( GMAB ) (“Genmab”) announced today that the conditions, including the minimum tender condition, to the previously announced tender offer (the “Offer”) by Genmab Holding...
Google to build subsea cables in Papua New Guinea under Australia defence treaty
Google to build subsea cables in Papua New Guinea under Australia defence treaty
Mar 10, 2026
SYDNEY, Dec 12 (Reuters) - Papua New Guinea said on Friday that Alphabet's Google will build three subsea cables, funded by Australia under a mutual defence treaty, in a key upgrade to the digital backbone of the biggest Pacific Island nation. Australian and U.S. military strategists view resource-rich but largely under-developed Papua New Guinea (PNG) as having a prized location...
Copyright 2023-2026 - www.financetom.com All Rights Reserved